Sanguine opens its first apheresis donor center in Los Angeles, CA
The center will specialize in collecting concentrated white blood cell biospecimens through apheresis (a.k.a. leukopaks) from participants in Sanguine’s Patient Community network. These research products facilitate advanced therapy development programs from discovery to manufacturing.
Coworker Donors: Achieving R&D goals with fast, fresh, on-demand biospecimens collected at your laboratory or office
Do you need reliable access to on-demand, fresh, healthy human biospecimens to accomplish R&D goals?
Join Sanguine Experts on Wednesday, October 4 @ 1:00 pm ET to learn how an Employer Onsite Collection program from Sanguine can streamline your specimen acquisition and enable your co-workers to contribute to your organization’s research initiatives.
Speakers Bio
Chelsea Bouvier, Sales enablement, Sanguine Biosciences
Chelsea has been at Sanguine for over 4.5 years and has worked on over 500 study designs with multiple large pharma and biotech companies across the US.
Megha manages both translational research studies and employee on-site donor programs for Sanguine. With over 3 years of experience of developing employee on-site donor programs, she has launched and managed 10+ programs for multiple large pharmas nationwide, resulting in 5,000+ successful sample collections supporting R&D.
A Fast and Fresh Feature for Translational Research
Read how an Onsite Employer Collection program can provide you with the freedom and flexibility to improve research initiatives in our latest blog.
Impact of delayed PBMC processing on functional and genomic assays
Yi, Zhuo, Lin et al J Immunol Methods (2023) 519, 113514 DOI: 10.1016/j.jim.2023.113514 Demonstrates the power of an onsite employer program in obtaining samples immediately after collection.
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection
Zhu, Cloney-Clark, Feng et al Microorganisms (2023) 11 (7) DOI: 10.3390/microorganisms11071789
